Gregory Karczmar

Research Summary
I have developed new approaches to functional and anatomic magnetic resonance imaging for over 30 years. I’ve applied these methods to improve detection and accurate diagnosis of cancer, and monitor cancer response to therapy. I am the Director of Magnetic Resonance Imaging Research at the University of Chicago, and Co-Director of the Advanced Imaging Program of the University of Chicago Comprehensive Cancer center. I’ve collaborated with our outstanding mammographic group and medical physics colleagues for many years to build internationally recognized research program in quantitative breast cancer MR imaging – which parallels and compliments a leading clinical program in breast cancer diagnosis and management. Similarly, I’ve collaborated with Dr. Oto and others to develop a leading translational research program focused on improving prostate cancer screening with MRI, and using MRI to guide therapye. With these collaborators, I’ve made pioneering contributions to MRI methods that improve prostate and breast cancer diagnosis and treatment. My research includes use of pre-clinical methods for breast and prostate cancer to improve understanding of cancer biology and guide the development of improved clinical methods.
Breast cancer screening with MRI, Prostate cancer screening with MRI, Community outreach, Screening iof underserved groups, Quantitative MRI
  • Reed College, Portland, B.A Physical Chemistry 06/1977
  • University of California at Berkeley, Berkeley, CA, Ph.D. Physical Chemistry 06/1984
Biosciences Graduate Program Association
  1. Szasz T, Lee G, Chatterjee A, Medved M, Devaraj A, Yousuf A, Fan X, Karczmar GS, Oto A. Physically implausible signals as a quantitative quality assessment metric in prostate diffusion-weighted MR imaging. Abdom Radiol (NY). 2022 Jul; 47(7):2500-2508. View in: PubMed

  2. Wu C, Hormuth D, Lorenzo G, Jarrett A, Pineda F, Howard FM, Karczmar G, Yankeelov TE. Towards patient-specific optimization of neoadjuvant treatment protocols for breast cancer based on image-guided fluid dynamics. IEEE Trans Biomed Eng. 2022 Apr 19; PP. View in: PubMed

  3. Ren Z, Pineda FD, Howard FM, Hill E, Szasz T, Safi R, Medved M, Nanda R, Yankeelov TE, Abe H, Karczmar GS. Differences Between Ipsilateral and Contralateral Early Parenchymal Enhancement Kinetics Predict Response of Breast Cancer to Neoadjuvant Therapy. Acad Radiol. 2022 Mar 26. View in: PubMed

  4. Chatterjee A, Antic T, Gallan AJ, Paner GP, Lin LI, Karczmar GS, Oto A. Histological validation of prostate tissue composition measurement using hybrid multi-dimensional MRI: agreement with pathologists' measures. Abdom Radiol (NY). 2022 02; 47(2):801-813. View in: PubMed

  5. Chatterjee A, Mercado C, Bourne RM, Yousuf A, Hess B, Antic T, Eggener S, Oto A, Karczmar GS. Validation of Prostate Tissue Composition by Using Hybrid Multidimensional MRI: Correlation with Histologic Findings. Radiology. 2022 02; 302(2):368-377. View in: PubMed

  6. Easley TO, Ren Z, Kim B, Karczmar GS, Barber RF, Pineda FD. Enhancement-constrained acceleration: A robust reconstruction framework in breast DCE-MRI. PLoS One. 2021; 16(10):e0258621. View in: PubMed

  7. Chatterjee A, Turchan WT, Fan X, Griffin A, Yousuf A, Karczmar GS, Liauw SL, Oto A. Can Pre-treatment Quantitative Multi-parametric MRI Predict the Outcome of Radiotherapy in Patients with Prostate Cancer? Acad Radiol. 2022 07; 29(7):977-985. View in: PubMed

  8. Fan X, Chatterjee A, Pittman JM, Yousuf A, Antic T, Karczmar GS, Oto A. Effectiveness of Dynamic Contrast Enhanced MRI with a Split Dose of Gadoterate Meglumine for Detection of Prostate Cancer. Acad Radiol. 2022 06; 29(6):796-803. View in: PubMed

  9. Wu C, Hormuth DA, Easley T, Eijkhout V, Pineda F, Karczmar GS, Yankeelov TE. An in silico validation framework for quantitative DCE-MRI techniques based on a dynamic digital phantom. Med Image Anal. 2021 10; 73:102186. View in: PubMed

  10. Whitney HM, Drukker K, Edwards A, Papaioannou J, Medved M, Karczmar G, Giger ML. Robustness of radiomic features of benign breast lesions and hormone receptor positive/HER2-negative cancers across DCE-MR magnet strengths. Magn Reson Imaging. 2021 10; 82:111-121. View in: PubMed

  11. Medved M, Chatterjee A, Devaraj A, Harmath C, Lee G, Yousuf A, Antic T, Oto A, Karczmar GS. High spectral and spatial resolution MRI of prostate cancer: a pilot study. Magn Reson Med. 2021 09; 86(3):1505-1513. View in: PubMed

  12. Gertsenshteyn I, Epel B, Barth E, Leoni L, Markiewicz E, Tsai HM, Fan X, Giurcanu M, Bodero D, Zamora M, Sundramoorthy S, Kim H, Freifelder R, Bhuiyan M, Kucharski A, Karczmar G, Kao CM, Halpern H, Chen CT. Improving Tumor Hypoxia Location in 18F-Misonidazole PET with Dynamic Contrast-enhanced MRI Using Quantitative Electron Paramagnetic Resonance Partial Oxygen Pressure Images. Radiol Imaging Cancer. 2021 03; 3(2):e200104. View in: PubMed

  13. Kim H, Hua Y, Chen HT, Tsai HM, Chen CT, Karczmar G, Fan X, Xi D, Xie Q, Chou CY, Kao CM. Design, evaluation and initial imaging results of a PET insert based on strip-line readout for simultaneous PET/MRI. Nucl Instrum Methods Phys Res A. 2020 Apr 11; 959. View in: PubMed

  14. Zhou X, Fan X, Mustafi D, Pineda F, Markiewicz E, Zamora M, Sheth D, Olopade OI, Oto A, Karczmar GS. Comparison of DCE-MRI of murine model cancers with a low dose and high dose of contrast agent. Phys Med. 2021 Jan; 81:31-39. View in: PubMed

  15. Fan X, Chatterjee A, Medved M, Oto A, Karczmar GS. Signal intensity form of the Tofts model for quantitative analysis of prostate dynamic contrast enhanced MRI data. Phys Med Biol. 2021 01 22; 66(2):025002. View in: PubMed

  16. Mustafi D, Valek R, Fitch M, Werner V, Fan X, Markiewicz E, Fernandez S, Zamora M, Mueller J, Olopade OI, Conzen SD, Brady MJ, Karczmar GS. Magnetic resonance angiography reveals increased arterial blood supply and tumorigenesis following high fat feeding in a mouse model of triple-negative breast cancer. NMR Biomed. 2020 10; 33(10):e4363. View in: PubMed

  17. Sun C, Wang S, Chatterjee A, Medved M, Eggener S, Karczmar GS, Oto A. T2*-weighted MRI as a non-contrast-enhanced method for assessment of focal laser ablation zone extent in prostate cancer thermotherapy. Eur Radiol. 2021 Jan; 31(1):325-332. View in: PubMed

  18. Foxley S, Wildenberg G, Sampathkumar V, Karczmar GS, Brugarolas P, Kasthuri N. Sensitivity to myelin using model-free analysis of the water resonance line-shape in postmortem mouse brain. Magn Reson Med. 2021 02; 85(2):667-677. View in: PubMed

  19. Penn AI, Medved M, Dialani V, Pisano ED, Cole EB, Brousseau D, Karczmar GS, Gao G, Reich BD, Abe H. Discrimination of benign from malignant breast lesions in dense breasts with model-based analysis of regions-of-interest using directional diffusion-weighted images. BMC Med Imaging. 2020 06 09; 20(1):61. View in: PubMed

  20. Wu C, Hormuth DA, Oliver TA, Pineda F, Lorenzo G, Karczmar GS, Moser RD, Yankeelov TE. Patient-Specific Characterization of Breast Cancer Hemodynamics Using Image-Guided Computational Fluid Dynamics. IEEE Trans Med Imaging. 2020 09; 39(9):2760-2771. View in: PubMed

  21. Chatterjee A, Nolan P, Sun C, Mathew M, Dwivedi D, Yousuf A, Antic T, Karczmar GS, Oto A. Effect of Echo Times on Prostate Cancer Detection on T2-Weighted Images. Acad Radiol. 2020 11; 27(11):1555-1563. View in: PubMed

  22. Pineda F, Sheth D, Abe H, Medved M, Karczmar GS. Low-dose imaging technique (LITE) MRI: initial experience in breast imaging. Br J Radiol. 2019 Nov; 92(1103):20190302. View in: PubMed

  23. Wang S, Fan X, Zhang Y, Medved M, He D, Yousuf A, Jamison E, Oto A, Karczmar GS. Use of Indicator Dilution Principle to Evaluate Accuracy of Arterial Input Function Measured With Low-Dose Ultrafast Prostate Dynamic Contrast-Enhanced MRI. Tomography. 2019 06; 5(2):260-265. View in: PubMed

  24. He D, Fan X, Chatterjee A, Wang S, Medved M, Pineda FD, Yousuf A, Antic T, Oto A, Karczmar GS. A compact solution for estimation of physiological parameters from ultrafast prostate dynamic contrast enhanced MRI. Phys Med Biol. 2019 08 07; 64(15):155012. View in: PubMed

  25. Chatterjee A, He D, Fan X, Antic T, Jiang Y, Eggener S, Karczmar GS, Oto A. Diagnosis of Prostate Cancer by Use of MRI-Derived Quantitative Risk Maps: A Feasibility Study. AJR Am J Roentgenol. 2019 08; 213(2):W66-W75. View in: PubMed

  26. Chatterjee A, Gallan AJ, He D, Fan X, Mustafi D, Yousuf A, Antic T, Karczmar GS, Oto A. Revisiting quantitative multi-parametric MRI of benign prostatic hyperplasia and its differentiation from transition zone cancer. Abdom Radiol (NY). 2019 06; 44(6):2233-2243. View in: PubMed

  27. Mustafi D, Leinroth A, Fan X, Markiewicz E, Zamora M, Mueller J, Conzen SD, Karczmar GS. Magnetic Resonance Angiography Shows Increased Arterial Blood Supply Associated with Murine Mammary Cancer. Int J Biomed Imaging. 2019; 2019:5987425. View in: PubMed

  28. Sun C, Chatterjee A, Yousuf A, Antic T, Eggener S, Karczmar GS, Oto A. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology. AJR Am J Roentgenol. 2019 02; 212(2):351-356. View in: PubMed

  29. Chatterjee A, Tokdemir S, Gallan AJ, Yousuf A, Antic T, Karczmar GS, Oto A. Multiparametric MRI Features and Pathologic Outcome of Wedge-Shaped Lesions in the Peripheral Zone on T2-Weighted Images of the Prostate. AJR Am J Roentgenol. 2019 01; 212(1):124-129. View in: PubMed

  30. Wu C, Pineda F, Hormuth DA, Karczmar GS, Yankeelov TE. Quantitative analysis of vascular properties derived from ultrafast DCE-MRI to discriminate malignant and benign breast tumors. Magn Reson Med. 2019 03; 81(3):2147-2160. View in: PubMed

  31. Wang S, Fan X, Yousuf A, Eggener SE, Karczmar G, Oto A. Evaluation of Focal Laser Ablation of Prostate Cancer Using High Spectral and Spatial Resolution Imaging: A Pilot Study. J Magn Reson Imaging. 2019 05; 49(5):1374-1380. View in: PubMed

  32. Mori N, Abe H, Mugikura S, Takasawa C, Sato S, Miyashita M, Mori Y, Pineda FD, Karczmar GS, Tamura H, Takahashi S, Takase K. Ultrafast Dynamic Contrast-Enhanced Breast MRI: Kinetic Curve Assessment Using Empirical Mathematical Model Validated with Histological Microvessel Density. Acad Radiol. 2019 07; 26(7):e141-e149. View in: PubMed

  33. Guindalini RSC, Zheng Y, Abe H, Whitaker K, Yoshimatsu TF, Walsh T, Schacht D, Kulkarni K, Sheth D, Verp MS, Bradbury AR, Churpek J, Obeid E, Mueller J, Khramtsova G, Liu F, Raoul A, Cao H, Romero IL, Hong S, Livingston R, Jaskowiak N, Wang X, Debiasi M, Pritchard CC, King MC, Karczmar G, Newstead GM, Huo D, Olopade OI. Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers. Clin Cancer Res. 2019 03 15; 25(6):1786-1794. View in: PubMed

  34. Mori N, Pineda FD, Tsuchiya K, Mugikura S, Takahashi S, Karczmar GS, Abe H. Fast Temporal Resolution Dynamic Contrast-Enhanced MRI: Histogram Analysis Versus Visual Analysis for Differentiating Benign and Malignant Breast Lesions. AJR Am J Roentgenol. 2018 10; 211(4):933-939. View in: PubMed

  35. Foxley S, Karczmar GS, Takahashi K. The effects of variations in tissue microstructure from postmortem rat brain on the asymmetry of the water proton resonance. Magn Reson Med. 2019 01; 81(1):79-89. View in: PubMed

  36. Westin C, Chatterjee A, Ku E, Yousuf A, Wang S, Thomas S, Fan X, Eggener S, Karczmar G, Oto A. MRI Findings After MRI-Guided Focal Laser Ablation of Prostate Cancer. AJR Am J Roentgenol. 2018 09; 211(3):595-604. View in: PubMed

  37. Chatterjee A, Devaraj A, Mathew M, Szasz T, Antic T, Karczmar GS, Oto A. Performance of T2 Maps in the Detection of Prostate Cancer. Acad Radiol. 2019 01; 26(1):15-21. View in: PubMed

  38. He D, Chatterjee A, Fan X, Wang S, Eggener S, Yousuf A, Antic T, Oto A, Karczmar GS. Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis. Invest Radiol. 2018 10; 53(10):609-615. View in: PubMed

  39. Chatterjee A, Bourne RM, Wang S, Devaraj A, Gallan AJ, Antic T, Karczmar GS, Oto A. Diagnosis of Prostate Cancer with Noninvasive Estimation of Prostate Tissue Composition by Using Hybrid Multidimensional MR Imaging: A Feasibility Study. Radiology. 2018 06; 287(3):864-873. View in: PubMed

  40. He D, Mustafi D, Fan X, Fernandez S, Markiewicz E, Zamora M, Mueller J, Sachleben JR, Brady MJ, Conzen SD, Karczmar GS. Magnetic resonance spectroscopy detects differential lipid composition in mammary glands on low fat, high animal fat versus high fructose diets. PLoS One. 2018; 13(1):e0190929. View in: PubMed

  41. Pineda FD, Easley TO, Karczmar GS. Dynamic field-of-view imaging to increase temporal resolution in the early phase of contrast media uptake in breast DCE-MRI: A feasibility study. Med Phys. 2018 Mar; 45(3):1050-1058. View in: PubMed

  42. Wang S, Lu Z, Fan X, Medved M, Jiang X, Sammet S, Yousuf A, Pineda F, Oto A, Karczmar GS. Comparison of arterial input functions measured from ultra-fast dynamic contrast enhanced MRI and dynamic contrast enhanced computed tomography in prostate cancer patients. Phys Med Biol. 2018 01 30; 63(3):03NT01. View in: PubMed

  43. Chatterjee A, He D, Fan X, Wang S, Szasz T, Yousuf A, Pineda F, Antic T, Mathew M, Karczmar GS, Oto A. Performance of Ultrafast DCE-MRI for Diagnosis of Prostate Cancer. Acad Radiol. 2018 03; 25(3):349-358. View in: PubMed

  44. McAuley EM, Mustafi D, Simons BW, Valek R, Zamora M, Markiewicz E, Lamperis S, Williams A, Roman BB, Vezina C, Karczmar G, Oto A, Vander Griend DJ. Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction. Am J Pathol. 2017 Nov; 187(11):2378-2387. View in: PubMed

  45. He D, Zamora M, Oto A, Karczmar GS, Fan X. Comparison of region-of-interest-averaged and pixel-averaged analysis of DCE-MRI data based on simulations and pre-clinical experiments. Phys Med Biol. 2017 Sep 05; 62(18):N445-N459. View in: PubMed

  46. Mustafi D, Fernandez S, Markiewicz E, Fan X, Zamora M, Mueller J, Brady MJ, Conzen SD, Karczmar GS. MRI reveals increased tumorigenesis following high fat feeding in a mouse model of triple-negative breast cancer. NMR Biomed. 2017 Oct; 30(10). View in: PubMed

  47. Mustafi D, Ward J, Dougherty U, Bissonnette M, Hart J, Vogt S, Karczmar GS. X-Ray Fluorescence Microscopy Demonstrates Preferential Accumulation of a Vanadium-Based Magnetic Resonance Imaging Contrast Agent in Murine Colonic Tumors. Mol Imaging. 2015 May 01; 14(5):7290201500001. View in: PubMed

  48. Karczmar GS, River LP, River J, Kovar D, Lewis MZ, Lee RC, Lipton MJ. Prospects for Assessment of the Effects of Electrical Injury by Magnetic Resonancea. Ann N Y Acad Sci. 1994 May; 720(1):176-180. View in: PubMed

  49. Jansen SA, Fan X, Karczmar GS, Abe H, Schmidt RA, Giger M, Newstead GM. DCEMRI of breast lesions: Is kinetic analysis equally effective for both mass and nonmass-like enhancement? Med Phys. 2008 Jul; 35(7Part1):3102-3109. View in: PubMed

  50. Markiewicz E, Fan X, Mustafi D, Zamora M, Conzen SD, Karczmar GS. MRI ductography of contrast agent distribution and leakage in normal mouse mammary ducts and ducts with in situ cancer. Magn Reson Imaging. 2017 07; 40:48-52. View in: PubMed

  51. Tsuchiya K, Mori N, Schacht DV, Sheth D, Karczmar GS, Newstead GM, Abe H. Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH). J Magn Reson Imaging. 2017 12; 46(6):1738-1747. View in: PubMed

  52. Medved M, Li H, Abe H, Sheth D, Newstead GM, Olopade OI, Giger ML, Karczmar GS. Fast bilateral breast coverage with high spectral and spatial resolution (HiSS) MRI at 3T. J Magn Reson Imaging. 2017 11; 46(5):1341-1348. View in: PubMed

  53. Wood AM, Shea SM, Medved M, Karczmar GS, Surucu M, Gros S, Small W, Roeske J. Spectral characterization of tissues in high spectral and spatial resolution MR images: Implications for a classification-based synthetic CT algorithm. Med Phys. 2017 May; 44(5):1865-1875. View in: PubMed

  54. Li H, Weiss WA, Medved M, Abe H, Newstead GM, Karczmar GS, Giger ML. Breast density estimation from high spectral and spatial resolution MRI. J Med Imaging (Bellingham). 2016 Oct; 3(4):044507. View in: PubMed

  55. Sweis RF, Medved M, Towey S, Karczmar GS, Oto A, Szmulewitz RZ, O'Donnell PH, Fishkin P, Karrison T, Stadler WM. Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma. Clin Genitourin Cancer. 2017 04; 15(2):207-212. View in: PubMed

  56. Abe H, Mori N, Tsuchiya K, Schacht DV, Pineda FD, Jiang Y, Karczmar GS. Kinetic Analysis of Benign and Malignant Breast Lesions With Ultrafast Dynamic Contrast-Enhanced MRI: Comparison With Standard Kinetic Assessment. AJR Am J Roentgenol. 2016 Nov; 207(5):1159-1166. View in: PubMed

  57. Sadinski M, Karczmar G, Peng Y, Wang S, Jiang Y, Medved M, Yousuf A, Antic T, Oto A. Pilot Study of the Use of Hybrid Multidimensional T2-Weighted Imaging-DWI for the Diagnosis of Prostate Cancer and Evaluation of Gleason Score. AJR Am J Roentgenol. 2016 Sep; 207(3):592-8. View in: PubMed

  58. Pineda FD, Medved M, Wang S, Fan X, Schacht DV, Sennett C, Oto A, Newstead GM, Abe H, Karczmar GS. Ultrafast Bilateral DCE-MRI of the Breast with Conventional Fourier Sampling: Preliminary Evaluation of Semi-quantitative Analysis. Acad Radiol. 2016 09; 23(9):1137-44. View in: PubMed

  59. Sammet S, Partanen A, Yousuf A, Sammet CL, Ward EV, Wardrip C, Niekrasz M, Antic T, Razmaria A, Farahani K, Sokka S, Karczmar G, Oto A. Cavernosal nerve functionality evaluation after magnetic resonance imaging-guided transurethral ultrasound treatment of the prostate. World J Radiol. 2015 Dec 28; 7(12):521-30. View in: PubMed

  60. Kitzing YX, Prando A, Varol C, Karczmar GS, Maclean F, Oto A. Benign Conditions That Mimic Prostate Carcinoma: MR Imaging Features with Histopathologic Correlation. Radiographics. 2016 Jan-Feb; 36(1):162-75. View in: PubMed

  61. Wang S, Fan X, Medved M, Pineda FD, Yousuf A, Oto A, Karczmar GS. Arterial input functions (AIFs) measured directly from arteries with low and standard doses of contrast agent, and AIFs derived from reference tissues. Magn Reson Imaging. 2016 Feb; 34(2):197-203. View in: PubMed

  62. Mustafi D, Gleber SC, Ward J, Dougherty U, Zamora M, Markiewicz E, Binder DC, Antic T, Vogt S, Karczmar GS, Oto A. IV Administered Gadodiamide Enters the Lumen of the Prostatic Glands: X-Ray Fluorescence Microscopy Examination of a Mouse Model. AJR Am J Roentgenol. 2015 Sep; 205(3):W313-9. View in: PubMed

  63. Chourasia AH, Tracy K, Frankenberger C, Boland ML, Sharifi MN, Drake LE, Sachleben JR, Asara JM, Locasale JW, Karczmar GS, Macleod KF. Mitophagy defects arising from BNip3 loss promote mammary tumor progression to metastasis. EMBO Rep. 2015 Sep; 16(9):1145-63. View in: PubMed

  64. Fan X, Macleod K, Mustafi D, Conzen SD, Markiewicz E, Zamora M, Vosicky J, Mueller J, Karczmar GS. Correlation of In Vivo and Ex Vivo ADC and T2 of In Situ and Invasive Murine Mammary Cancers. PLoS One. 2015; 10(7):e0129212. View in: PubMed

  65. Weiss WA, Medved M, Karczmar GS, Giger ML. Preliminary assessment of dispersion versus absorption analysis of high spectral and spatial resolution magnetic resonance images in the diagnosis of breast cancer. J Med Imaging (Bellingham). 2015 Apr; 2(2):024502. View in: PubMed

  66. Mustafi D, Zamora M, Fan X, Markiewicz E, Mueller J, Conzen SD, Karczmar GS. MRI accurately identifies early murine mammary cancers and reliably differentiates between in situ and invasive cancer: correlation of MRI with histology. NMR Biomed. 2015 Sep; 28(9):1078-86. View in: PubMed

  67. Pineda FD, Medved M, Fan X, Karczmar GS. B1 and T1 mapping of the breast with a reference tissue method. Magn Reson Med. 2016 Apr; 75(4):1565-73. View in: PubMed

  68. Mustafi D, Ward J, Dougherty U, Bissonnette M, Hart J, Vogt S, Karczmar GS. X-ray fluorescence microscopy demonstrates preferential accumulation of a vanadium-based magnetic resonance imaging contrast agent in murine colonic tumors. Mol Imaging. 2015; 14. View in: PubMed

  69. Sadinski M, Medved M, Karademir I, Wang S, Peng Y, Jiang Y, Sammet S, Karczmar G, Oto A. Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostate. Abdom Imaging. 2015 Oct; 40(7):2523-8. View in: PubMed

  70. Pineda FD, Medved M, Fan X, Ivancevic MK, Abe H, Shimauchi A, Newstead GM, Karczmar GS. Comparison of dynamic contrast-enhanced MRI parameters of breast lesions at 1.5 and 3.0?T: a pilot study. Br J Radiol. 2015 May; 88(1049):20150021. View in: PubMed

  71. Foxley S, Domowicz M, Karczmar GS, Schwartz N. 3D high spectral and spatial resolution imaging of ex vivo mouse brain. Med Phys. 2015 Mar; 42(3):1463-72. View in: PubMed

  72. Fan X, Mustafi D, Markiewicz E, Zamora M, Vosicky J, Leinroth A, Mueller J, Macleod K, Conzen SD, Karczmar GS. Mammary cancer initiation and progression studied with magnetic resonance imaging. Breast Cancer Res. 2014 Dec 16; 16(6):495. View in: PubMed

  73. Dougherty U, Mustafi R, Sadiq F, Almoghrabi A, Mustafi D, Kreisheh M, Sundaramurthy S, Liu W, Konda VJ, Pekow J, Khare S, Hart J, Joseph L, Wyrwicz A, Karczmar GS, Li YC, Bissonnette M. The renin-angiotensin system mediates EGF receptor-vitamin d receptor cross-talk in colitis-associated colon cancer. Clin Cancer Res. 2014 Nov 15; 20(22):5848-5859. View in: PubMed

  74. Markiewicz E, Fan X, Mustafi D, Zamora M, Roman BB, Jansen SA, Macleod K, Conzen SD, Karczmar GS. High resolution 3D MRI of mouse mammary glands with intra-ductal injection of contrast media. Magn Reson Imaging. 2015 Jan; 33(1):161-5. View in: PubMed

  75. Medved M, Soylu-Boy FN, Karademir I, Sethi I, Yousuf A, Karczmar GS, Oto A. High-resolution diffusion-weighted imaging of the prostate. AJR Am J Roentgenol. 2014 Jul; 203(1):85-90. View in: PubMed

  76. Hipp E, Fan X, Partanen A, Vosicky J, Pelizzari CA, Straus CM, Sokka S, Karczmar GS. Quantitative evaluation of internal marks made using MRgFUS as seen on MRI, CT, US, and digital color images - a pilot study. Phys Med. 2014 Dec; 30(8):941-6. View in: PubMed

  77. Hansford BG, Karademir I, Peng Y, Jiang Y, Karczmar G, Thomas S, Yousuf A, Antic T, Eggener S, Oto A. Dynamic contrast-enhanced MR imaging features of the normal central zone of the prostate. Acad Radiol. 2014 May; 21(5):569-77. View in: PubMed

  78. Weiss WA, Medved M, Karczmar GS, Giger ML. Residual analysis of the water resonance signal in breast lesions imaged with high spectral and spatial resolution (HiSS) MRI: a pilot study. Med Phys. 2014 Jan; 41(1):012303. View in: PubMed

  79. Mustafi D, Shiou SR, Fan X, Markiewicz E, Karczmar GS, Claud EC. MRI of neonatal necrotizing enterocolitis in a rodent model. NMR Biomed. 2014 Mar; 27(3):272-9. View in: PubMed

  80. Karademir I, Shen D, Peng Y, Liao S, Jiang Y, Yousuf A, Karczmar G, Sammet S, Wang S, Medved M, Antic T, Eggener S, Oto A. Prostate volumes derived from MRI and volume-adjusted serum prostate-specific antigen: correlation with Gleason score of prostate cancer. AJR Am J Roentgenol. 2013 Nov; 201(5):1041-8. View in: PubMed

  81. Bhooshan N, Giger M, Medved M, Li H, Wood A, Yuan Y, Lan L, Marquez A, Karczmar G, Newstead G. Potential of computer-aided diagnosis of high spectral and spatial resolution (HiSS) MRI in the classification of breast lesions. J Magn Reson Imaging. 2014 Jan; 39(1):59-67. View in: PubMed

  82. Wang S, Peng Y, Medved M, Yousuf AN, Ivancevic MK, Karademir I, Jiang Y, Antic T, Sammet S, Oto A, Karczmar GS. Hybrid multidimensional T(2) and diffusion-weighted MRI for prostate cancer detection. J Magn Reson Imaging. 2014 Apr; 39(4):781-8. View in: PubMed

  83. Oto A, Sethi I, Karczmar G, McNichols R, Ivancevic MK, Stadler WM, Watson S, Eggener S. MR imaging-guided focal laser ablation for prostate cancer: phase I trial. Radiology. 2013 Jun; 267(3):932-40. View in: PubMed

  84. Wood AM, Medved M, Bacchus ID, Al-Hallaq HA, Shimauchi A, Newstead GM, Olopade OI, Venkataraman SS, Ivancevic MK, Karczmar GS. Classification of breast lesions pre-contrast injection using water resonance lineshape analysis. NMR Biomed. 2013 May; 26(5):569-77. View in: PubMed

  85. Abe H, Shimauchi A, Fan X, River JN, Sattar H, Mueller J, Karczmar GS, Newstead GM. Comparing post-operative human breast specimen radiograph and MRI in lesion margin and volume assessment. J Appl Clin Med Phys. 2012 Nov 08; 13(6):3802. View in: PubMed

  86. Medved M, Karczmar GS, Newstead GM. Do we really need contrast agents? Eur J Radiol. 2012 Sep; 81 Suppl 1:S99-100. View in: PubMed

  87. Haney CR, Fan X, Markiewicz E, Mustafi D, Karczmar GS, Stadler WM. Monitoring anti-angiogenic therapy in colorectal cancer murine model using dynamic contrast-enhanced MRI: comparing pixel-by-pixel with region of interest analysis. Technol Cancer Res Treat. 2013 Feb; 12(1):71-8. View in: PubMed

  88. Leach MO, Morgan B, Tofts PS, Buckley DL, Huang W, Horsfield MA, Chenevert TL, Collins DJ, Jackson A, Lomas D, Whitcher B, Clarke L, Plummer R, Judson I, Jones R, Alonzi R, Brunner T, Koh DM, Murphy P, Waterton JC, Parker G, Graves MJ, Scheenen TW, Redpath TW, Orton M, Karczmar G, Huisman H, Barentsz J, Padhani A. Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. Eur Radiol. 2012 Jul; 22(7):1451-64. View in: PubMed

  89. Foxley S, Fan X, River J, Zamora M, Markiewicz E, Sokka S, Karczmar GS. Hyperthermically induced changes in high spectral and spatial resolution MR images of tumor tissue--a pilot study. Phys Med Biol. 2012 May 07; 57(9):2653-66. View in: PubMed

  90. Hipp E, Partanen A, Karczmar GS, Fan X. Safety limitations of MR-HIFU treatment near interfaces: a phantom validation. J Appl Clin Med Phys. 2012 Mar 08; 13(2):3739. View in: PubMed

  91. Hipp E, Fan X, Jansen SA, Markiewicz EJ, Vosicky J, Newstead GM, Conzen SD, Krausz T, Karczmar GS. T(2)* relaxation times of intraductal murine mammary cancer, invasive mammary cancer, and normal mammary gland. Med Phys. 2012 Mar; 39(3):1309-13. View in: PubMed

  92. Kayhan A, Yang C, Soylu FN, Lakadamyali H, Sethi I, Karczmar G, Stadler W, Oto A. Dynamic contrast-enhanced MR imaging findings of bone metastasis in patients with prostate cancer. World J Radiol. 2011 Oct 28; 3(10):241-5. View in: PubMed

  93. Oto A, Yang C, Kayhan A, Tretiakova M, Antic T, Schmid-Tannwald C, Eggener S, Karczmar GS, Stadler WM. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. AJR Am J Roentgenol. 2011 Dec; 197(6):1382-90. View in: PubMed

  94. Medved M, Fan X, Abe H, Newstead GM, Wood AM, Shimauchi A, Kulkarni K, Ivancevic MK, Pesce LL, Olopade OI, Karczmar GS. Non-contrast enhanced MRI for evaluation of breast lesions: comparison of non-contrast enhanced high spectral and spatial resolution (HiSS) images versus contrast enhanced fat-suppressed images. Acad Radiol. 2011 Dec; 18(12):1467-74. View in: PubMed

  95. Fan X, Haney CR, Agrawal G, Pelizzari CA, Antic T, Eggener SE, Sethi I, River JN, Zamora M, Karczmar GS, Oto A. High-resolution MRI of excised human prostate specimens acquired with 9.4T in detection and identification of cancers: validation of a technique. J Magn Reson Imaging. 2011 Oct; 34(4):956-61. View in: PubMed

  96. Jansen SA, Shimauchi A, Zak L, Fan X, Karczmar GS, Newstead GM. The diverse pathology and kinetics of mass, nonmass, and focus enhancement on MR imaging of the breast. J Magn Reson Imaging. 2011 Jun; 33(6):1382-9. View in: PubMed

  97. Haney CR, Pelizzari CA, Foxley S, Zamora MA, Mustafi D, Tretiakova M, Li S, Fan X, Karczmar GS. HiSStology: high spectral and spatial resolution magnetic resonance imaging detection of vasculature validated by histology and micro-computed tomography. Mol Imaging. 2011 Jun; 10(3):187-96. View in: PubMed

  98. Jansen SA, Lin VC, Giger ML, Li H, Karczmar GS, Newstead GM. Normal parenchymal enhancement patterns in women undergoing MR screening of the breast. Eur Radiol. 2011 Jul; 21(7):1374-82. View in: PubMed

  99. Jansen SA, Conzen SD, Fan X, Markiewicz E, Krausz T, Newstead GM, Karczmar GS. In vivo MRI of early stage mammary cancers and the normal mouse mammary gland. NMR Biomed. 2011 Aug; 24(7):880-7. View in: PubMed

  100. Jansen SA, Fan X, Medved M, Abe H, Shimauchi A, Yang C, Zamora M, Foxley S, Olopade OI, Karczmar GS, Newstead GM. Characterizing early contrast uptake of ductal carcinoma in situ with high temporal resolution dynamic contrast-enhanced MRI of the breast: a pilot study. Phys Med Biol. 2010 Oct 07; 55(19):N473-85. View in: PubMed

  101. Oto A, Kayhan A, Jiang Y, Tretiakova M, Yang C, Antic T, Dahi F, Shalhav AL, Karczmar G, Stadler WM. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology. 2010 Dec; 257(3):715-23. View in: PubMed

  102. Haney CR, Fan X, Parasca AD, Karczmar GS, Halpern HJ, Pelizzari CA. Immobilization Using Dental Material Casts Facilitates Accurate Serial and Multimodality Small Animal Imaging. Concepts Magn Reson Part B Magn Reson Eng. 2008 Apr; 33B(2):138-144. View in: PubMed

  103. Heisen M, Fan X, Buurman J, van Riel NA, Karczmar GS, ter Haar Romeny BM. The use of a reference tissue arterial input function with low-temporal-resolution DCE-MRI data. Phys Med Biol. 2010 Aug 21; 55(16):4871-83. View in: PubMed

  104. Fan X, Haney CR, Mustafi D, Yang C, Zamora M, Markiewicz EJ, Karczmar GS. Use of a reference tissue and blood vessel to measure the arterial input function in DCEMRI. Magn Reson Med. 2010 Dec; 64(6):1821-6. View in: PubMed

  105. Yang C, Stadler WM, Karczmar GS, Milosevic M, Yeung I, Haider MA. Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT. Magn Reson Med. 2010 Jun; 63(6):1601-9. View in: PubMed

  106. Medved M, Ivancevic MK, Olopade OI, Newstead GM, Karczmar GS. Echo-planar spectroscopic imaging (EPSI) of the water resonance structure in human breast using sensitivity encoding (SENSE). Magn Reson Med. 2010 Jun; 63(6):1557-63. View in: PubMed

  107. Mustafi D, Fan X, Dougherty U, Bissonnette M, Karczmar GS, Oto A, Hart J, Markiewicz E, Zamora M. High-resolution magnetic resonance colonography and dynamic contrast-enhanced magnetic resonance imaging in a murine model of colitis. Magn Reson Med. 2010 Apr; 63(4):922-9. View in: PubMed

  108. Heisen M, Fan X, Buurman J, van Riel NA, Karczmar GS, ter Haar Romeny BM. The influence of temporal resolution in determining pharmacokinetic parameters from DCE-MRI data. Magn Reson Med. 2010 Mar; 63(3):811-6. View in: PubMed

  109. Jansen SA, Paunesku T, Fan X, Woloschak GE, Vogt S, Conzen SD, Krausz T, Newstead GM, Karczmar GS. Ductal carcinoma in situ: X-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine model. Radiology. 2009 Nov; 253(2):399-406. View in: PubMed

  110. Jansen SA, Fan X, Yang C, Shimauchi A, Karczmar G, Newstead GM. Relating dose of contrast media administered to uptake and washout of malignant lesions on DCEMRI of the breast. Acad Radiol. 2010 Jan; 17(1):24-30. View in: PubMed

  111. Medved M, Newstead GM, Fan X, Du YP, Olopade OI, Shimauchi A, Zamora MA, Karczmar GS. Fourier component imaging of water resonance in the human breast provides markers for malignancy. Phys Med Biol. 2009 Oct 07; 54(19):5767-79. View in: PubMed

  112. Jansen SA, Conzen SD, Fan X, Markiewicz EJ, Newstead GM, Karczmar GS. Magnetic resonance imaging of the natural history of in situ mammary neoplasia in transgenic mice: a pilot study. Breast Cancer Res. 2009; 11(5):R65. View in: PubMed

  113. Jansen SA, Shimauchi A, Zak L, Fan X, Wood AM, Karczmar GS, Newstead GM. Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition. AJR Am J Roentgenol. 2009 Sep; 193(3):832-9. View in: PubMed

  114. Fan X, Mustafi D, Zamora M, River JN, Foxley S, Karczmar GS. Can DCEMRI assess the effect of green tea on the angiogenic properties of rodent prostate tumors? Phys Med. 2010 Apr; 26(2):111-6. View in: PubMed

  115. Medved M, Newstead GM, Abe H, Olopade OI, Shimauchi A, Zamora MA, Karczmar GS. Clinical implementation of a multislice high spectral and spatial resolution-based MRI sequence to achieve unilateral full-breast coverage. Magn Reson Imaging. 2010 Jan; 28(1):16-21. View in: PubMed

  116. Mustafi D, Peng B, Foxley S, Makinen MW, Karczmar GS, Zamora M, Ejnik J, Martin H. New vanadium-based magnetic resonance imaging probes: clinical potential for early detection of cancer. J Biol Inorg Chem. 2009 Nov; 14(8):1187-97. View in: PubMed

  117. Oto A, Fan X, Mustafi D, Jansen SA, Karczmar GS, Rubin DT, Kayhan A. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study. Acad Radiol. 2009 Oct; 16(10):1223-30. View in: PubMed

  118. Haney CR, Parasca AD, Fan X, Bell RM, Zamora MA, Karczmar GS, Mauceri HJ, Halpern HJ, Weichselbaum RR, Pelizzari CA. Characterization of response to radiation mediated gene therapy by means of multimodality imaging. Magn Reson Med. 2009 Aug; 62(2):348-56. View in: PubMed

  119. Fan X, Karczmar GS. A new approach to analysis of the impulse response function (IRF) in dynamic contrast-enhanced MRI (DCEMRI): a simulation study. Magn Reson Med. 2009 Jul; 62(1):229-39. View in: PubMed

  120. Oto A, Zhu F, Kulkarni K, Karczmar GS, Turner JR, Rubin D. Evaluation of diffusion-weighted MR imaging for detection of bowel inflammation in patients with Crohn's disease. Acad Radiol. 2009 May; 16(5):597-603. View in: PubMed

  121. Yang C, Karczmar GS, Medved M, Oto A, Zamora M, Stadler WM. Reproducibility assessment of a multiple reference tissue method for quantitative dynamic contrast enhanced-MRI analysis. Magn Reson Med. 2009 Apr; 61(4):851-9. View in: PubMed

  122. Foxley S, Fan X, Mustafi D, Haney C, Zamora M, Markiewicz E, Medved M, Wood AM, Karczmar GS. Sensitivity to tumor microvasculature without contrast agents in high spectral and spatial resolution MR images. Magn Reson Med. 2009 Feb; 61(2):291-8. View in: PubMed

  123. Hahn OM, Yang C, Medved M, Karczmar G, Kistner E, Karrison T, Manchen E, Mitchell M, Ratain MJ, Stadler WM. Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma. J Clin Oncol. 2008 Oct 01; 26(28):4572-8. View in: PubMed

  124. Jansen SA, Conzen SD, Fan X, Krausz T, Zamora M, Foxley S, River J, Newstead GM, Karczmar GS. Detection of in situ mammary cancer in a transgenic mouse model: in vitro and in vivo MRI studies demonstrate histopathologic correlation. Phys Med Biol. 2008 Oct 07; 53(19):5481-93. View in: PubMed

  125. Foxley S, Fan X, Jansen SA, Zamora M, Markiewicz E, Al-Ahmadie H, Karczmar GS. High spectral and spatial resolution MRI of age-related changes in murine prostate. Magn Reson Med. 2008 Sep; 60(3):575-81. View in: PubMed

  126. Jansen SA, Fan X, Karczmar GS, Abe H, Schmidt RA, Giger M, Newstead GM. DCEMRI of breast lesions: is kinetic analysis equally effective for both mass and nonmass-like enhancement? Med Phys. 2008 Jul; 35(7):3102-9. View in: PubMed

  127. Foxley S, Fan X, Mustafi D, Yang C, Zamora MA, Medved M, Karczmar GS. Quantitative analysis of water proton spectral lineshape: a novel source of contrast in MRI. Phys Med Biol. 2008 Sep 07; 53(17):4509-22. View in: PubMed

  128. Jansen SA, Fan X, Karczmar GS, Abe H, Schmidt RA, Newstead GM. Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast-enhanced MRI: a sensitivity and specificity study. Magn Reson Med. 2008 Apr; 59(4):747-54. View in: PubMed

  129. Jansen SA, Newstead GM, Abe H, Shimauchi A, Schmidt RA, Karczmar GS. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology. 2007 Dec; 245(3):684-91. View in: PubMed

  130. Yang C, Karczmar GS, Medved M, Stadler WM. Multiple reference tissue method for contrast agent arterial input function estimation. Magn Reson Med. 2007 Dec; 58(6):1266-75. View in: PubMed

  131. Ehrichs EE, Jaeger HM, Karczmar GS, Knight JB, Kuperman VY, Nagel SR. Granular convection observed by magnetic resonance imaging. Science. 1995 Mar 17; 267(5204):1632-4. View in: PubMed

  132. Fan X, Medved M, Karczmar GS, Yang C, Foxley S, Arkani S, Recant W, Zamora MA, Abe H, Newstead GM. Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrast-enhanced MRI. Magn Reson Imaging. 2007 Jun; 25(5):593-603. View in: PubMed

  133. Puri N, Khramtsov A, Ahmed S, Nallasura V, Hetzel JT, Jagadeeswaran R, Karczmar G, Salgia R. A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts. Cancer Res. 2007 Apr 15; 67(8):3529-34. View in: PubMed

  134. Lee RC, Despa F, Collins JC, Karczmar G, Tenchov B. Magnetic resonance imaging of muscle electroporation injury. Conf Proc IEEE Eng Med Biol Soc. 2004; 2004:5451-4. View in: PubMed

  135. Fan X, Markiewicz EJ, Zamora M, Karczmar GS, Roman BB. Comparison and evaluation of mouse cardiac MRI acquired with open birdcage, single loop surface and volume birdcage coils. Phys Med Biol. 2006 Dec 21; 51(24):N451-9. View in: PubMed

  136. Fan X, Abe H, Medved M, Foxley S, Arkani S, Zamora MA, Olopade OI, Newstead GM, Karczmar GS. Fat suppression with spectrally selective inversion vs. high spectral and spatial resolution MRI of breast lesions: qualitative and quantitative comparisons. J Magn Reson Imaging. 2006 Dec; 24(6):1311-5. View in: PubMed

  137. Gissel H, Despa F, Collins J, Mustafi D, Rojahn K, Karczmar G, Lee R. Magnetic resonance imaging of changes in muscle tissues after membrane trauma. Ann N Y Acad Sci. 2005 Dec; 1066:272-85. View in: PubMed

  138. Cheng X, Lechman JB, Fernandez-Barbero A, Grest GS, Jaeger HM, Karczmar GS, Möbius ME, Nagel SR. Three-dimensional shear in granular flow. Phys Rev Lett. 2006 Jan 27; 96(3):038001. View in: PubMed

  139. Fan X, Medved M, Foxley S, River JN, Zamora M, Karczmar GS, Corot C, Robert P, Bourrinet P. Multi-slice DCE-MRI data using P760 distinguishes between metastatic and non-metastatic rodent prostate tumors. MAGMA. 2006 Feb; 19(1):15-21. View in: PubMed

  140. Fan X, River JN, Muresan AS, Popescu C, Zamora M, Culp RM, Karczmar GS. MRI of perfluorocarbon emulsion kinetics in rodent mammary tumours. Phys Med Biol. 2006 Jan 21; 51(2):211-20. View in: PubMed

  141. Medved M, Newstead GM, Abe H, Zamora MA, Olopade OI, Karczmar GS. High spectral and spatial resolution MRI of breast lesions: preliminary clinical experience. AJR Am J Roentgenol. 2006 Jan; 186(1):30-7. View in: PubMed

  142. Möbius ME, Cheng X, Eshuis P, Karczmar GS, Nagel SR, Jaeger HM. Effect of air on granular size separation in a vibrated granular bed. Phys Rev E Stat Nonlin Soft Matter Phys. 2005 Jul; 72(1 Pt 1):011304. View in: PubMed

  143. Du W, Du W, Fan X, Foxley S, Zamora M, River JN, Culp RM, Karczmar GS. Comparison of high-resolution echo-planar spectroscopic imaging with conventional MR imaging of prostate tumors in mice. NMR Biomed. 2005 Aug; 18(5):285-92. View in: PubMed

  144. Du W, Karczmar GS, Uftring SJ, Du YP. Anatomical and functional brain imaging using high-resolution echo-planar spectroscopic imaging at 1.5 Tesla. NMR Biomed. 2005 Jun; 18(4):235-41. View in: PubMed

  145. Möbius ME, Cheng X, Karczmar GS, Nagel SR, Jaeger HM. Intruders in the dust: air-driven granular size separation. Phys Rev Lett. 2004 Nov 05; 93(19):198001. View in: PubMed

  146. Yang C, Karczmar GS, Medved M, Stadler WM. Estimating the arterial input function using two reference tissues in dynamic contrast-enhanced MRI studies: fundamental concepts and simulations. Magn Reson Med. 2004 Nov; 52(5):1110-7. View in: PubMed

  147. Medved M, Newstead GM, Fan X, Du W, Du YP, MacEneaney PM, Culp RM, Kelcz F, Olopade OI, Zamora MA, Karczmar GS. Fourier components of inhomogeneously broadened water resonances in breast: a new source of MRI contrast. Magn Reson Med. 2004 Jul; 52(1):193-6. View in: PubMed

  148. Medved M, Karczmar G, Yang C, Dignam J, Gajewski TF, Kindler H, Vokes E, MacEneany P, Mitchell MT, Stadler WM. Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time. J Magn Reson Imaging. 2004 Jul; 20(1):122-8. View in: PubMed

  149. Peterson AC, Swiger S, Stadler WM, Medved M, Karczmar G, Gajewski TF. Phase II study of the Flk-1 tyrosine kinase inhibitor SU5416 in advanced melanoma. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):4048-54. View in: PubMed

  150. Fan X, Medved M, River JN, Zamora M, Corot C, Robert P, Bourrinet P, Lipton M, Culp RM, Karczmar GS. New model for analysis of dynamic contrast-enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors. Magn Reson Med. 2004 Mar; 51(3):487-94. View in: PubMed

  151. al-Hallaq HA, Zamora MA, Fish BL, Halpern HJ, Moulder JE, Karczmar GS. Using high spectral and spatial resolution bold MRI to choose the optimal oxygenating treatment for individual cancer patients. Adv Exp Med Biol. 2003; 530:433-40. View in: PubMed

  152. Medved M, Du W, Zamora MA, Fan X, Olopade OI, MacEneaney PM, Newstead G, Karczmar GS. The effect of varying spectral resolution on the quality of high spectral and spatial resolution magnetic resonance images of the breast. J Magn Reson Imaging. 2003 Oct; 18(4):442-8. View in: PubMed

  153. Du W, Du YP, Fan X, Zamora MA, Karczmar GS. Reduction of spectral ghost artifacts in high-resolution echo-planar spectroscopic imaging of water and fat resonances. Magn Reson Med. 2003 Jun; 49(6):1113-20. View in: PubMed

  154. Elas M, Williams BB, Parasca A, Mailer C, Pelizzari CA, Lewis MA, River JN, Karczmar GS, Barth ED, Halpern HJ. Quantitative tumor oxymetric images from 4D electron paramagnetic resonance imaging (EPRI): methodology and comparison with blood oxygen level-dependent (BOLD) MRI. Magn Reson Med. 2003 Apr; 49(4):682-91. View in: PubMed

  155. Fan X, River JN, Zamora M, Al-Hallaq HA, Karczmar GS. Effect of carbogen on tumor oxygenation: combined fluorine-19 and proton MRI measurements. Int J Radiat Oncol Biol Phys. 2002 Nov 15; 54(4):1202-9. View in: PubMed

  156. Fan X, Du W, MacEneaney P, Zamora M, Karczmar G. Structure of the water resonance in small voxels in rat brain detected with high spectral and spatial resolution MRI. J Magn Reson Imaging. 2002 Nov; 16(5):547-52. View in: PubMed

  157. Gillies RJ, Raghunand N, Karczmar GS, Bhujwalla ZM. MRI of the tumor microenvironment. J Magn Reson Imaging. 2002 Oct; 16(4):430-50. View in: PubMed

  158. Du W, Karczmar GS, Pan X. Effects of constant frequency noise in magnetic resonance imaging with nonuniform k-space sampling. Med Phys. 2002 Aug; 29(8):1832-8. View in: PubMed

  159. Karczmar GS, Du W, Medved M, Bick U, MacEneany P, Du YP, Fan X, Zamora M, Lipton M. Spectrally inhomogeneous effects of contrast agents in breast lesion detected by high spectral and spatial resolution MRI. Acad Radiol. 2002 Aug; 9 Suppl 2:S352-4. View in: PubMed

  160. Du W, Du YP, Bick U, Fan X, MacEneaney PM, Zamora MA, Medved M, Karczmar GS. Breast MR imaging with high spectral and spatial resolutions: preliminary experience. Radiology. 2002 Aug; 224(2):577-85. View in: PubMed

  161. Karczmar GS, Fan X, Al-Hallaq H, River JN, Tarlo K, Kellar KE, Zamora M, Rinker-Schaeffer C, Lipton MJ. Functional and anatomic imaging of tumor vasculature: high-resolution MR spectroscopic imaging combined with a superparamagnetic contrast agent. Acad Radiol. 2002 May; 9 Suppl 1:S115-8. View in: PubMed

  162. Williams BB, al Hallaq H, Chandramouli GV, Barth ED, Rivers JN, Lewis M, Galtsev VE, Karczmar GS, Halpern HJ. Imaging spin probe distribution in the tumor of a living mouse with 250 MHz EPR: correlation with BOLD MRI. Magn Reson Med. 2002 Apr; 47(4):634-8. View in: PubMed

  163. Al-Hallaq HA, Fan X, Zamora M, River JN, Moulder JE, Karczmar GS. Spectrally inhomogeneous BOLD contrast changes detected in rodent tumors with high spectral and spatial resolution MRI. NMR Biomed. 2002 Feb; 15(1):28-36. View in: PubMed

  164. Fan X, River JN, Zamora M, Tarlo K, Kellar K, Rinker-Schaeffer C, Karczmar GS. Differentiation of nonmetastatic and metastatic rodent prostate tumors with high spectral and spatial resolution MRI. Magn Reson Med. 2001 Jun; 45(6):1046-55. View in: PubMed

  165. Evelhoch JL, Gillies RJ, Karczmar GS, Koutcher JA, Maxwell RJ, Nalcioglu O, Raghunand N, Ronen SM, Ross BD, Swartz HM. Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia. 2000 Jan-Apr; 2(1-2):152-65. View in: PubMed

  166. Al-Hallaq HA, Zamora M, Fish BL, Farrell A, Moulder JE, Karczmar GS. MRI measurements correctly predict the relative effects of tumor oxygenating agents on hypoxic fraction in rodent BA1112 tumors. Int J Radiat Oncol Biol Phys. 2000 May 01; 47(2):481-8. View in: PubMed

  167. Karczmar GS, Fan X, Al-Hallaq HA, Zamora M, River JN, Rinker-Schaeffer C, Zaucha M, Tarlo K, Kellar K. Uptake of a superparamagnetic contrast agent imaged by MR with high spectral and spatial resolution. Magn Reson Med. 2000 May; 43(5):633-9. View in: PubMed

  168. Kovar DA, Lewis M, Karczmar GS. A new method for imaging perfusion and contrast extraction fraction: input functions derived from reference tissues. J Magn Reson Imaging. 1998 Sep-Oct; 8(5):1126-34. View in: PubMed

  169. Al-Hallaq HA, River JN, Zamora M, Oikawa H, Karczmar GS. Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. Int J Radiat Oncol Biol Phys. 1998 Apr 01; 41(1):151-9. View in: PubMed

  170. Kovar DA, Al-Hallaq HA, Zamora MA, River JN, Karczmar GS. Fast spectroscopic imaging of water and fat resonances to improve the quality of MR images. Acad Radiol. 1998 Apr; 5(4):269-75. View in: PubMed

  171. Kovar DA, Lewis MZ, River JN, Lipton MJ, Karczmar GS. In vivo imaging of extraction fraction of low molecular weight MR contrast agents and perfusion rate in rodent tumors. Magn Reson Med. 1997 Aug; 38(2):259-68. View in: PubMed

  172. Oikawa H, al-Hallaq HA, Lewis MZ, River JN, Kovar DA, Karczmar GS. Spectroscopic imaging of the water resonance with short repetition time to study tumor response to hyperoxia. Magn Reson Med. 1997 Jul; 38(1):27-32. View in: PubMed

  173. Kuperman VY, Karczmar GS, Blomley MJ, Lewis MZ, Lubich LM, Lipton MJ. Differentiating between T1 and T2* changes caused by gadopentetate dimeglumine in the kidney by using a double-echo dynamic MR imaging sequence. J Magn Reson Imaging. 1996 Sep-Oct; 6(5):764-8. View in: PubMed

  174. Kovar DA, Lipton MJ, Lewis MZ, River JN, Lubich L, Karczmar GS. Dynamic contrast measurements in rodent model tumors. Acad Radiol. 1996 Aug; 3 Suppl 2:S384-6. View in: PubMed

  175. Halpern HJ, Yu C, Peric M, Barth ED, Karczmar GS, River JN, Grdina DJ, Teicher BA. Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry. Radiat Res. 1996 May; 145(5):610-8. View in: PubMed

  176. Karczmar G, River J, Koretsky AP. Radiofrequency magnetic field gradient echoes have reduced sensitivity to susceptibility gradients. Magn Reson Imaging. 1995; 13(6):791-7. View in: PubMed

  177. Karczmar GS, River JN, Li J, Vijayakumar S, Goldman Z, Lewis MZ. Effects of hyperoxia on T2* and resonance frequency weighted magnetic resonance images of rodent tumours. NMR Biomed. 1994 Mar; 7(1-2):3-11. View in: PubMed

  178. Karczmar GS, River LP, River J, Kovar D, Lewis MZ, Lee RC, Lipton MJ. Prospects for assessment of the effects of electrical injury by magnetic resonance. Ann N Y Acad Sci. 1994 May 31; 720:176-80. View in: PubMed

  179. Karczmar GS, River JN, Goldman Z, Li J, Weisenberg E, Lewis MZ, Liu K. Magnetic resonance imaging of rodent tumors using radiofrequency gradient echoes. Magn Reson Imaging. 1994; 12(6):881-93. View in: PubMed

  180. Karczmar GS, Kuperman VY, River JN, Lewis MZ, Lipton MJ. Magnetic resonance measurement of response to hyperoxia differentiates tumors from normal tissue and may be sensitive to oxygen consumption. Invest Radiol. 1994 Jun; 29 Suppl 2:S161-3. View in: PubMed

  181. Changes in T2*-weighted images during hyperoxia differentiate tumors from normal tissue. Magn Reson Med. 1995 Mar; 33(3):318-25. View in: PubMed

  182. Karczmar GS, Matson GB, Weiner MW. A single acquisition localization technique. Magn Reson Med. 1986 Apr; 3(2):341-5. View in: PubMed

  183. Schaefer S, Gober J, Valenza M, Karczmar GS, Matson GB, Camacho SA, Botvinick EH, Massie B, Weiner MW. Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heart. J Am Coll Cardiol. 1988 Dec; 12(6):1449-55. View in: PubMed

  184. Matson GB, Twieg DB, Karczmar GS, Lawry TJ, Gober JR, Valenza M, Boska MD, Weiner MW. Application of image-guided surface coil P-31 MR spectroscopy to human liver, heart, and kidney. Radiology. 1988 Nov; 169(2):541-7. View in: PubMed

  185. Arbeit JM, Toy BJ, Karczmar GS, Hubesch A, Weiner MW. Inhibition of tumor high-energy phosphate metabolism by insulin combined with rhodamine 123. Surgery. 1988 Aug; 104(2):161-70. View in: PubMed

  186. Karczmar GS, Twieg DB, Lawry TJ, Matson GB, Weiner MW. Detection of motion using B1 gradients. Magn Reson Med. 1988 May; 7(1):111-6. View in: PubMed

  187. Karczmar GS, Tavares NJ, Moseley ME. Use of radio-frequency field gradients to image blood flow and perfusion in vivo. Radiology. 1989 Aug; 172(2):363-6. View in: PubMed

  188. Karczmar GS, Kurtz T, Tavares NJ, Weiner MW. Regulation of hepatic inorganic phosphate and ATP in response to fructose loading: an in vivo 31P-NMR study. Biochim Biophys Acta. 1989 Jul 11; 1012(2):121-7. View in: PubMed

  189. Karczmar GS, Tavares NJ, Weiner MW. A 31P NMR study of the GI tract: effect of fructose loading and measurement of transverse relaxation times. Magn Reson Med. 1989 Jan; 9(1):8-15. View in: PubMed

  190. Shine N, Palladino MA, Patton JS, Deisseroth A, Karczmar GS, Matson GB, Weiner MW. Early metabolic response to tumor necrosis factor in mouse sarcoma: a phosphorus-31 nuclear magnetic resonance study. Cancer Res. 1989 Apr 15; 49(8):2123-7. View in: PubMed

  191. Weiner MW, Hetherington H, Hubesch B, Karczmar G, Massie B, Maudsley A, Meyerhoff DJ, Sappey-Marinier D, Schaefer S, Twieg DB, et al. Clinical magnetic resonance spectroscopy of brain, heart, liver, kidney, and cancer. A quantitative approach. NMR Biomed. 1989 Dec; 2(5-6):290-7. View in: PubMed

  192. Karczmar GS, Shine N, Lawry TJ, Weiner MW, Matson GB. Improvement of the rotating frame experiment by detection of residual Z magnetization: a 31P MRS study of metabolite levels in a Meth-A sarcoma. NMR Biomed. 1989 Apr; 1(4):159-64. View in: PubMed

  193. Meyerhoff DJ, Karczmar GS, Weiner MW. Abnormalities of the liver evaluated by 31P MRS. Invest Radiol. 1989 Dec; 24(12):980-4. View in: PubMed

  194. Karczmar GS, Meyerhoff DJ, Speder A, Valone F, Wilkinson M, Shine N, Boska MD, Weiner MW. Response of tumors to therapy studied by 31P magnetic resonance spectroscopy. Invest Radiol. 1989 Dec; 24(12):1020-3. View in: PubMed

  195. Lawry TJ, Karczmar GS, Weiner MW, Matson GB. Computer simulation of MRS localization techniques: an analysis of ISIS. Magn Reson Med. 1989 Mar; 9(3):299-314. View in: PubMed

  196. Boska MD, Meyerhoff DJ, Twieg DB, Karczmar GS, Matson GB, Weiner MW. Image-guided 31P magnetic resonance spectroscopy of normal and transplanted human kidneys. Kidney Int. 1990 Aug; 38(2):294-300. View in: PubMed

  197. Meyerhoff DJ, Karczmar GS, Matson GB, Boska MD, Weiner MW. Non-invasive quantitation of human liver metabolites using image-guided 31P magnetic resonance spectroscopy. NMR Biomed. 1990 Feb; 3(1):17-22. View in: PubMed

  198. Boska MD, Hubesch B, Meyerhoff DJ, Twieg DB, Karczmar GS, Matson GB, Weiner MW. Comparison of 31P MRS and 1H MRI at 1.5 and 2.0 T. Magn Reson Med. 1990 Feb; 13(2):228-38. View in: PubMed

  199. Karczmar GS, Meyerhoff DJ, Boska MD, Hubesch B, Poole J, Matson GB, Valone F, Weiner MW. P-31 spectroscopy study of response of superficial human tumors to therapy. Radiology. 1991 Apr; 179(1):149-53. View in: PubMed

  200. Gober JR, Schwartz GG, Schaefer S, Massie BM, Matson GB, Weiner MW, Karczmar GS. 31P MRS of myocardial inorganic phosphate using radiofrequency gradient echoes. Magn Reson Med. 1991 Aug; 20(2):171-83. View in: PubMed

  201. Karczmar GS, Arbeit JM, Toy BJ, Speder A, Weiner MW. Selective depletion of tumor ATP by 2-deoxyglucose and insulin, detected by 31P magnetic resonance spectroscopy. Cancer Res. 1992 Jan 01; 52(1):71-6. View in: PubMed

  202. Meyerhoff DJ, Karczmar GS, Valone F, Venook A, Matson GB, Weiner MW. Hepatic cancers and their response to chemoembolization therapy. Quantitative image-guided 31P magnetic resonance spectroscopy. Invest Radiol. 1992 Jun; 27(6):456-64. View in: PubMed

  203. Karczmar GS, Tritton TR. The interaction of adriamycin with small unilamellar vesicle liposomes. A fluorescence study. Biochim Biophys Acta. 1979 Nov 02; 557(2):306-19. View in: PubMed